InspireMD Investor Relations Material
Latest events
Q2 2025
InspireMD
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from InspireMD Inc
Access all reports
InspireMD Inc. is a medical device company specializing in the development and commercialization of its proprietary MicroNet stent platform technology. This technology is primarily aimed at addressing complex vascular and coronary diseases. The company's key products include the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard prime embolic protection system, which are designed for carotid artery applications and coronary interventions, respectively. InspireMD's strategy involves selling its medical devices through local distribution partners, extending its reach across multiple regions. The company was established in 2005 and is headquartered in Tel Aviv-Yafo, Israel. Its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NSPR
Country
🇺🇸 United States